FEMY is trading 5.9% down today at $3.84 as the stock undergoes profit-taking following several volatile sessions and a pre-market spike that lacked a clear fundamental driver.
- The move appears to be driven by typical low-float biotech volatility, with no fresh company-specific news or regulatory filings reported today.
- The decline coincides with a broadly weaker market environment where major indices are also trading lower.